A share price of Jade Biosciences Inc [JBIO] is currently trading at $11.14, up 3.15%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The JBIO shares have gain 20.43% over the last week, with a monthly amount glided 53.66%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Jade Biosciences Inc [NASDAQ: JBIO] stock has seen the most recent analyst activity on June 16, 2025, when Guggenheim upgraded its rating to a Buy but kept the price target unchanged to $14 for it. Previously, Wedbush started tracking the stock with Outperform rating on May 07, 2025, and set its price target to $17. On May 05, 2025, Stifel initiated with a Buy rating and assigned a price target of $19 on the stock. TD Cowen started tracking the stock assigning a Buy rating and suggested a price target of $10 on May 02, 2025. Wells Fargo downgraded its rating to a Equal Weight and reduced its price target to $2 on June 18, 2024. TD Cowen downgraded its rating to Hold for this stock on June 18, 2024. In a note dated June 18, 2024, Evercore ISI downgraded an In-line rating on this stock and revised its target price from $27 to $2.
Jade Biosciences Inc experienced fluctuations in its stock price throughout the past year between $5.74 and $13.50. Currently, Wall Street analysts expect the stock to reach $16.5 within the next 12 months. Jade Biosciences Inc [NASDAQ: JBIO] shares were valued at $11.14 at the most recent close of the market. An investor can expect a potential return of 48.11% based on the average JBIO price forecast.
Analyzing the JBIO fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -1.29, Equity is 2.01 and Total Capital is -1.17. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -2.3.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 10.41 points at the first support level, and at 9.68 for the second support level. However, for the 1st resistance point, the stock is sitting at 11.60, and for the 2nd resistance point, it is at 12.06.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Jade Biosciences Inc [NASDAQ:JBIO] is 32.01. Also, the Quick Ratio is 32.01, while the Cash Ratio stands at 5.78.
Transactions by insiders
Recent insider trading involved Atlas Venture Fund XII, L.P., Shareholder, that happened on Jun 25 ’25 when 28977.0 shares were purchased. Shareholder, Atlas Venture Associates XII, completed a deal on Jun 25 ’25 to buy 235.0 shares. Meanwhile, Shareholder Atlas Venture Fund XII, L.P. bought 16132.0 shares on Jun 24 ’25.
